about
New directions for rabbit antithymocyte globulin (Thymoglobulin(®)) in solid organ transplants, stem cell transplants and autoimmunityTLR9 activation induces normal neutrophil responses in a child with IRAK-4 deficiency: involvement of the direct PI3K pathwaySirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients.A three-arm study comparing immediate tacrolimus therapy with antithymocyte globulin induction therapy followed by tacrolimus or cyclosporine A in adult renal transplant recipients.Supernatant from bifidobacterium differentially modulates transduction signaling pathways for biological functions of human dendritic cells.Induction therapy by anti-thymocyte globulin (rabbit) in renal transplantation: a 1-yr follow-up of safety and efficacy.Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults.Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome.TCF7L2 polymorphism associates with new-onset diabetes after transplantation.Performance of the new mycophenolate assay based on IMPDH enzymatic activity for pharmacokinetic investigations and setup of Bayesian estimators in different populations of allograft recipients.The Orai-1 and STIM-1 complex controls human dendritic cell maturationRisk factors for impaired CD4+ T-cell reconstitution following rabbit antithymocyte globulin treatment in kidney transplantationEffects of immunosuppressive drugs on dendritic cells and tolerance induction.Correction of postkidney transplant anemia reduces progression of allograft nephropathy.Bayesian estimation of cyclosporin exposure for routine therapeutic drug monitoring in kidney transplant patientsMutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells.Unexpected impairment of TNF-α-induced maturation of human dendritic cells in vitro by IL-4Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national surveyGenome-Wide Association Study of Acute Renal Graft Rejection.mTOR inhibition: the learning curve in kidney transplantation.Rabbit antithymocyte globulin (thymoglobulin): 25 years and new frontiers in solid organ transplantation and haematology.Revisiting the effects of CMV on long-term transplant outcome.The role of Thymoglobulin induction in kidney transplantation: an update.Prognostic significance of graft Foxp3 expression in renal transplant recipients: a critical review and attempt to reconcile discrepancies.Conversion to mTOR-inhibitor-based immunosuppression: which patients and when?
P50
Q26823090-E65B48E9-C069-4A02-812E-DAC7CD57CEFFQ28646169-B9272A24-C976-4BDA-9835-6E5F7504DEDDQ33332340-931428D5-48C1-4E5C-9C36-744715A4FBFAQ33347170-E933AD16-7D2B-4B0E-9944-C57E5E96887EQ33354056-5B6BF190-CFF4-4A1F-BFF0-FB5890189233Q33358816-810854D0-ED0E-4E3C-B3BA-CD43B799EE28Q33405246-BCF1F8F2-3191-42FB-9AFA-FFD479158813Q33408211-9FE7C3A7-F764-4970-9154-AEF7BA6B5EB7Q33561720-C1D74726-3FE5-4587-822E-5191BB9DF72DQ34077882-440CF6F9-7759-4CC6-8303-F42ABBBF0CAAQ34734948-CDC1686B-F89A-464E-84BB-C4B8A4AE5963Q34805780-BD66BF67-5EA3-433D-B11E-5731898F14B1Q35159612-A78CBBFF-EF32-4A84-97D9-F44A0ABFE6EEQ35715841-C95BDBF2-7170-498E-B582-6C7227F1AB6EQ35827273-06D6E2B2-9D8F-43A1-8CD8-4AD7ACD9BD03Q36742242-2FF35EE9-B0CB-43B2-AFFB-3309CED251B5Q36800386-40D4DF18-0D50-41C7-A99E-59FDE9A7D7D3Q36923083-0ABE524C-2AE3-4D17-BB6A-6C4EA90C1143Q37560649-63FC32D8-DE45-4D0E-B280-448719034081Q37688221-189B658A-E1D4-43EA-847E-23A4E97BD032Q37731525-5D6B7A69-A64E-49FA-8861-CA59D4843CB3Q37772750-D56A545E-60AC-49B3-810E-AAF9050D73E7Q38051718-1956F00A-01AD-41BB-9844-4D30CD34E271Q38069412-A5A21AD7-0362-4099-9518-1627DACC2FFAQ38190678-E297EB50-FEF9-4E33-A167-718DF20F3996
P50
description
inmunólogu francés
@ast
médecin
@fr
عالم مناعة فرنسي
@ar
name
Yvon Lebranchu
@ast
Yvon Lebranchu
@ca
Yvon Lebranchu
@de
Yvon Lebranchu
@en
Yvon Lebranchu
@es
Yvon Lebranchu
@fr
Yvon Lebranchu
@it
Yvon Lebranchu
@nl
Yvon Lebranchu
@sl
type
label
Yvon Lebranchu
@ast
Yvon Lebranchu
@ca
Yvon Lebranchu
@de
Yvon Lebranchu
@en
Yvon Lebranchu
@es
Yvon Lebranchu
@fr
Yvon Lebranchu
@it
Yvon Lebranchu
@nl
Yvon Lebranchu
@sl
prefLabel
Yvon Lebranchu
@ast
Yvon Lebranchu
@ca
Yvon Lebranchu
@de
Yvon Lebranchu
@en
Yvon Lebranchu
@es
Yvon Lebranchu
@fr
Yvon Lebranchu
@it
Yvon Lebranchu
@nl
Yvon Lebranchu
@sl
P214
P269
P106
P19
P21
P214
P269
P27
P31
P3956
P4124
yvon-lebranchu_69615
P569
1947-05-10T00:00:00Z
P735
P7859
viaf-197786001